{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Tampa",
      "state": "FL",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "80128",
      "recalling_firm": "Shoreside Enterprises Inc.",
      "address_1": "6345 Newtown Cir Apt A3 Ste A-3",
      "address_2": "N/A",
      "postal_code": "33615-3629",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Nationwide.",
      "recall_number": "D-0879-2018",
      "product_description": "POSEIDON Xtreme PLATINUM 4500,1000mg, packaged in single packs sold in 24-count boxes, Distributed by: Poseidon Distribution Atlanta, GA, UPC 638632428857",
      "product_quantity": "Unknown",
      "reason_for_recall": "Marketed Without An Approved NDA/ANDA: FDA analysis found products to contain undeclared sildenafil and tadalafil. The presence of sildenafil and tadalafil makes these products an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall.",
      "recall_initiation_date": "20180517",
      "center_classification_date": "20180618",
      "termination_date": "20200610",
      "report_date": "20180606",
      "code_info": "Lot #: 201117BL, Exp. 01/2020"
    }
  ]
}